UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2 Journal article
Duncton M.A.J., Piatnitski Chekler E.L., Katoch-Rouse R., Sherman D., Wong W.C., Smith II L.M., Kawakami J.K., Kiselyov A.S., Milligan D.L., Balagtas C., Hadari Y.R., Wang Y., Patel S.N., Rolster R.L., Tonra J.R., Surguladze D., Mitelman S., Kussie P., Bohlen P., Doody J.F.. Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2[J]. Bioorganic and Medicinal Chemistry, 2009, 17(2), 731-740.
Authors:  Duncton M.A.J.;  Piatnitski Chekler E.L.;  Katoch-Rouse R.;  Sherman D.;  Wong W.C.; et al.
Favorite | TC[WOS]:38 TC[Scopus]:38 | Submit date:2019/01/16
Angiogenesis  Arylphthalazine  Inhibitor  Kdr  Kinase  Phthalazine  Vegfr-2  
Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors Journal article
Smith II L., Piatnitski E.L., Kiselyov A.S., Ouyang X., Chen X., Burdzovic-Wizemann S., Xu Y., Wang Y., Rosler R.L., Patel S.N., Chiang H.-H., Milligan D.L., Columbus J., Wong W.C., Doody J.F., Hadari Y.R.. Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors[J]. Bioorganic and Medicinal Chemistry Letters, 2006, 16(6), 1643-1646.
Authors:  ; et al.
Favorite | TC[WOS]:20 TC[Scopus]:19 | Submit date:2019/01/16
Benzoxazepine  Epidermal Growth Factor Receptor  Kinase Inhibitor  Kinase Selectivity  
Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors Journal article
Ouyang X., Chen X., Piatnitski E.L., Kiselyov A.S., He H.-Y., Mao Y., Pattaropong V., Yu Y., Kim K.H., Kincaid J., Smith II L., Wong W.C., Lee S.P., Milligan D.L., Malikzay A., Fleming J., Gerlak J., Deevi D., Doody J.F., Chiang H.-H., Patel S.N., Wang Y., Rolser R.L., Kussie P., Labelle M., Tuma M.C.. Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors[J]. Bioorganic and Medicinal Chemistry Letters, 2005, 15(23), 5154-5159.
Authors:  Ouyang X.;  Chen X.;  Piatnitski E.L.;  Kiselyov A.S.;  He H.-Y.; et al.
Favorite | TC[WOS]:66 TC[Scopus]:70 | Submit date:2019/01/16
1,2,4-triazole  Antimitotic  Tubulin Inhibitor  Tubulin Polymerization  Tumor Vasculature  Vascular Disrupting Agent